Hamdi Ahmed M, Fida Madiha, Abu Saleh Omar M, Beam Elena
Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA.
Open Forum Infect Dis. 2020 Jan 19;7(1):ofaa008. doi: 10.1093/ofid/ofaa008. eCollection 2020 Jan.
is a gram-negative, opportunistic infection that is usually hospital-acquired and associated with high morbidity and mortality. The reported increase in infections is presumed to be due to an increase in the population at risk.
We retrospectively reviewed 10-year data for bacteremia in hospitalized adults at our institution to determine the population at risk, sources of infection, common complications, antimicrobial susceptibility profiles, and clinical outcome trends over the past decade.
Among the 98 patients analyzed, the most common source of infection was catheter-related (62, 63.3%). Most isolates (61, 65%) were resistant to ceftazidime; fewer were resistant to trimethoprim-sulfamethoxazole (TMP-SMX; 2, 2.1%) and levofloxacin (22, 23.4%). All-cause in-hospital mortality was 29.6% (29 patients). The highest mortality, 53.8%, was observed in pulmonary sources of bacteremia.
Although TMP-SMX continues to have reliable activity in our cohort, we noted resistance to TMP-SMX in patients with recent TMP-SMX exposure, including a case with developing resistance to TMP-SMX while on therapy.
[病原体名称]是一种革兰氏阴性菌,属于机会性感染,通常为医院获得性感染,与高发病率和高死亡率相关。据报道,[病原体名称]感染的增加被认为是由于高危人群数量增加所致。
我们回顾性分析了本机构10年间住院成人[病原体名称]菌血症的数据,以确定高危人群、感染源、常见并发症、抗菌药物敏感性谱以及过去十年的临床结局趋势。
在分析的98例患者中,最常见的感染源是与导管相关的(62例,63.3%)。大多数分离株(61例,65%)对头孢他啶耐药;对甲氧苄啶-磺胺甲恶唑(TMP-SMX;2例,2.1%)和左氧氟沙星(22例,23.4%)耐药的较少。全因住院死亡率为29.6%(29例患者)。菌血症肺部感染源的死亡率最高,为53.8%。
尽管TMP-SMX在我们的队列中仍具有可靠的活性,但我们注意到近期接触过TMP-SMX的患者对TMP-SMX耐药,包括1例在治疗期间出现对TMP-SMX耐药的病例。